Christopher E. Barbieri
NewYork–Presbyterian Hospital(US)Cornell University(US)New York Hospital Queens(US)Lander Institute(IL)Presbyterian Hospital(US)Weill Cornell Medicine(US)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, interferon and immune responses, PARP inhibition in cancer therapy, Prostate Cancer Diagnosis and Treatment, Herpesvirus Infections and Treatments
Most-Cited Works
- → The Molecular Taxonomy of Primary Prostate Cancer(2015)3,177 cited
- → Punctuated Evolution of Prostate Cancer Genomes(2013)1,340 cited
- → The long tail of oncogenic drivers in prostate cancer(2018)876 cited
- → Prostate cancer–associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4(2017)333 cited
- → FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes(2019)274 cited
- → Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnover(2013)254 cited